𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone

✍ Scribed by Claudia Zierold; Jamie A. Mings; Hector F. DeLuca


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
100 KB
Volume
88
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The 25‐hydroxyvitamin D~3~‐24‐hydroxylase mRNA is tightly and reciprocally regulated by 1,25‐dihydroxyvitamin D~3~ (1,25(OH)~2~D~3~) and parathyroid hormone (PTH). The upregulation of the 24‐hydroxylase by 1,25(OH)~2~D~3~ is well established and occurs at the transcriptional level through two vitamin D response elements in the promoter of the gene. However, this induction is blocked by the protein synthesis inhibitor cycloheximide (CHX) indicating a protein component in the regulation pathway. CHX treatment reduced total vitamin D receptor (VDR) protein levels in cells, but reintroduction of VDR and/or retinoid X receptor protein into cells by transfection did not reduce the inhibition by CHX. This indicates that production of another transcription factor or mRNA‐stabilizing protein synthesized in response to 1,25(OH)~2~D~3~ is required for optimal accumulation of 24‐hydroxylase mRNA. PTH downregulates the 24‐hydroxylase mRNA by affecting its stability. The half‐life of 24‐hydroxylase mRNA is reduced 4.2‐fold in AOK‐B50 cells by PTH. Untranslated regions of the 24‐hydroxylase mRNA in reporter gene assays did not confer PTH responsiveness. Further analysis of the coding region of the rat 24‐hydroxylase may reveal sites of action of PTH. J. Cell. Biochem. 88: 234–237, 2003. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


1α,25-Dihydroxy-3-Epi-vitamin D3, a natu
✍ A.J. Brown; C. Ritter; E. Slatopolsky; K.R. Muralidharan; W.H. Okamura; G.S. Red 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

1␣,25(OH) 2 D 3 is an important negative regulator of parathyroid hormone (PTH) gene transcription. In parathyroid cells, as in other target tissues, 1␣,25(OH) 2 D 3 is degraded by side chain oxidation by the inducible 24-hydroxylase. We have previously shown that one metabolite of this pathway, 1␣,

Mechanism of 24,25-dihydroxyvitamin D3-m
✍ Ilka Nemere; Cody Wilson; Wendy Jensen; Marla Steinbeck; Ben Rohe; Mary C. Farac 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

In intestine, 24,25(OH) 2 D 3 , which is made under conditions of calcium-, phosphate-, and 1,25(OH) 2 D 3 sufficiency, inhibits the stimulatory actions of 1,25(OH) 2 D 3 on phosphate and calcium absorption. In the current work, we provide evidence that 24,25(OH) 2 D 3 -mediated signal transduction

Nongenomic actions of the steroid hormon
✍ Daniel T. Baran 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Recent studies indicate that the vitamin D hormone, 1 a,25-dihydroxyvitamin D3 exerts rapid effects (seconds to minutes) in a variety of cell types. These rapid nongenomic actions in osteoblasts include effects on membrane voltage-gated calcium channels, phospholipase C activity, and the sodium/hydr